申请人:SCHERING AKTIENGESELLSCHAFT
公开号:EP0158775A1
公开(公告)日:1985-10-23
Novel substituted sulfonamidobenzamides and their preparation by known methods are described as useful antiarrhythmic agents. Their use in the treatment of cardiac arrhythmias, especially re-entrant arrhythmias, via the prolongation of the action potential of cardiac tissue is provided. Pharmaceutical formulations containing such compounds are also disclosed.
新型取代磺酰胺基苯甲酰胺及其已知制备方法被描述为有用的抗心律失常药物,可通过延长心脏组织的动作电位治疗心律失常,尤其是再发性心律失常。 还公开了含有此类化合物的药物制剂。